Analysis reveals changes in mutational signatures for doublet-base substitutions in lung adenocarcinoma, suggesting new insights for Chinese patients.
The proportion of different mutational signatures that underlie the doublet-base substitutions (DBS) over different mutation periods.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: